Latest Blogs

Nagi S. El Saghir, MD, FASCO, FACP
Oct 27, 2020
COVID-19 Pandemic, Online Oncology, and Breast Self-Exam
In Lebanon, as elsewhere, we are concerned that many patients are avoiding clinic and hospital visits for fear of catching coronavirus. We therefore decided to focus our October 2020 awareness campaign on breast self-examination at home.
Anne Katz, PhD, RN, FAAN
Oct 27, 2020
Mourning the Loss of Sexual Function
I wasn’t sure what the patient's response would be to my suggestion for mourning after prostate cancer treatment, but I thought it was worth talking about.
Guest Commentary
Oct 27, 2020
Reflections on ASCO’s Oncology Student Interest Group Program: Benefits and Opportunities for Young Trainees and Medical Students
An OSIG is "an ideal opportunity for us to be active in public health, advocacy, leadership, and education with a major focus on cancer prevention and screening, increasing the quality of life of patients and their families, as well as healthy living," writes Ms. Duaa Kanan.
Inas Abuali, MD, FACP
Oct 01, 2020
Developing Your Professional Niche as an Academic Clinician-Educator
There are established channels to demonstrate your productivity and follow a career path in research and practice. However, if you're passionate about education, you have to think creatively about how to carve out your niche and show your abilities.
Subscribe to this column

Edward Paul Balaban, DO, FACP, FASCO

Edward P. Balaban, DO, FACP, FASCO, is the medical director for the Cancer Care Partnership with Penn State University Cancer Institute and professor of medicine at Penn State Hershey Cancer Institute. He has served as a Practice Guideline Implementation Network (PGIN) representative for Weight-Based Dosing Chemotherapy for Cancer Patients and Gastrointestinal Guideline Advisory Groups. Dr. Balaban is past president of the Pennsylvania Society of Oncology and Hematology. He serves as an ASCO delegate to the American Medical Association House of Delegates (AMA HOD).

Disclosure.

Jun 10, 2020
We Are All In This Together
Although our societal meetings, including the AMA House of Delegates meeting, are shortened, they have never been more important than they are at this moment.
Dec 03, 2019
AMA House of Delegates: Nothing Is Done Without Your Help
ASCO's delegation to the AMA HOD invites all ASCO members to share their thoughts and concerns concerning issues affecting the practice of oncology, as your input directly impacts the delegation's work.
Jun 20, 2019
ASCO’s Delegation at the AMA House of Delegates: So Much More to Do
Key cancer-related topics discussed at the AMA-HOD meeting included alcohol ingestion as a causation risk factor, appropriate guidelines for opioids in the cancer setting, and the use of de-identified patient information.
Nov 19, 2018
AMA House of Delegates: This Timeline Grows Short
At a recent meeting, the ASCO delegation to the AMA House of Delegates presented concerns focused on the Competitive Acquisition Program (CAP), among a variety of other issues.
Jun 22, 2018
So Busy and So Worthwhile: ASCO and the AMA House of Delegates
At the most recent meeting, ASCO's delegation to the AMA House of Delegates were involved in resolutions related to Pharmacy Benefit Managers, opioids, billing for survivorship care plans, alcohol as a modifiable risk for cancer, and more.
Nov 20, 2017
Aloha from the ASCO AMA House of Delegates
The ASCO delegation was very busy at the American Medical Association House of Delegates recent interim meeting.

Pages